Print   

Tuesday 24 August, 2010

Interserve PLC

Contract Win


                   INTERSERVE APPOINTED TO £4.5bn PROCURE21+                   

                            NHS FRAMEWORK AGREEMENT                            

Interserve, the international services, maintenance and building group, has
been named as one of the six Principal Supply Chain Partners (PCSPs) in the new
ProCure21+ framework agreement, estimated to be worth up to £4.5 billion over
its six-year term.

ProCure21+ will begin operating on 1st October 2010. It is a new framework that
will replace the current ProCure21 programme through which Interserve has
undertaken 136 schemes on behalf of 52 NHS Trusts since its pilot in 2002. Like
ProCure21 the framework will streamline and improve the procurement process for
NHS Trusts across England. This will enable them to select an appropriate
supply chain partner to deliver acute, primary care and mental health
facilities. As with ProCure21, there is a commitment to long-term
relationships, collaborative working, integrated supply chains and the use of
target-cost contracts.

There are a number of new features in ProCure21+ including:

* A centrally-provided risk evaluation tool for all schemes to improve
  consistency and share approaches to managing common risks.
   
* A central repository of technical drawings and information that can be
  re-used by all clients and supply-chain members under the "NHS Royalty-Free
  Licence".
   
* An online "monthly monitoring" performance management system with a reduced
  benchmarking data set to manage scheme performance centrally.
   
* Provision of a project start-up workshop by PCSPs on all schemes to align
  stakeholder and supply chain requirements early in the process.
   
* Assurance of a VAT-compliant PSCP structure to maximise VAT recovery for
  NHS Clients.
   
Commenting on Interserve's selection as a Principal Supply Chain Partner,
Adrian Ringrose, Chief Executive, said, "The creation of ProCure21+ is
excellent news. Under ProCure21 Interserve has been able to deliver many
high-quality, value-for-money facilities and ProCure21+ will enable us to
continue enhancing the health environment to meet the changing needs of the
NHS. We are well positioned to do this as the only Health Framework Partner
supporting the NHS across England, Scotland and Wales."

                                   - Ends -                                    


For further information please contact:

Amanda Cardall                                       0121 331 8125             
Corporate Marketing Manager                                                    
                                                                               
Elizabeth Morley / Tom Eckersley                     020 7379 5151             
Maitland                                                                       


About Interserve

Over the last five years Interserve has delivered healthcare projects with a
total value of approximately £500 million, most of which has been through
ProCure21.

Interserve's vision is to be the Trusted Partner of all our stakeholders. We
are one of the world's foremost support services and construction companies,
operating in the public and private sectors in the UK and internationally. We
offer advice, design, construction and facilities management services for
society's infrastructure and provide a range of plant and equipment in
specialist fields. Interserve is based in the UK. It has revenue of £1.9
billion and a workforce of 50,000 people worldwide.

Health website:          www.health.interserve.com                             
General website:         www.interserve.com.                                   



Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.